EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Annals of the Rheumatic Diseases
O Kowal-BieleckaEUSTAR Co-Authors

Abstract

The optimal treatment of systemic sclerosis (SSc) is a challenge because the pathogenesis of SSc is unclear and it is an uncommon and clinically heterogeneous disease affecting multiple organ systems. The aim of the European League Against Rheumatism (EULAR) Scleroderma Trials and Research group (EUSTAR) was to develop evidence-based, consensus-derived recommendations for the treatment of SSc. To obtain and maintain a high level of intrinsic quality and comparability of this approach, EULAR standard operating procedures were followed. The task force comprised 18 SSc experts from Europe, the USA and Japan, two SSc patients and three fellows for literature research. The preliminary set of research questions concerning SSc treatment was provided by 74 EUSTAR centres. Based on discussion of the clinical research evidence from published literature, and combining this with current expert opinion and clinical experience, 14 recommendations for the treatment of SSc were formulated. The final set includes the following recommendations: three on SSc-related digital vasculopathy (Raynaud's phenomenon and ulcers); four on SSc-related pulmonary arterial hypertension; three on SSc-related gastrointestinal involvement; two on scleroderma rena...Continue Reading

Citations

May 11, 2012·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·N HunzelmannUNKNOWN Kooperationspartner der DNSS
Apr 12, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·N Hunzelmann
Sep 27, 2012·Rheumatology International·Afsha A Topal, Rachita S Dhurat
May 22, 2010·Zeitschrift für Rheumatologie·M Dougados
Apr 28, 2012·Zeitschrift für Rheumatologie·M O Becker, G Riemekasten
Jun 16, 2012·Zeitschrift für Rheumatologie·M Janneck, C Iking-Konert
Nov 7, 2013·Zeitschrift für Rheumatologie·I Kötter, J C Henes
Mar 5, 2013·Zeitschrift für Rheumatologie·P OstojicB Stojic
Dec 15, 2010·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Sanjeev BawejaLawrence P McMahon
Apr 28, 2011·Clinical Rheumatology·Malgorzata E KrzyszczakMinoru Satoh
Aug 10, 2012·Clinical Rheumatology·Lucie HromadkovaJiri Vlcek
Jul 3, 2013·Clinical Rheumatology·Gemma StricklandNeil McHugh
Nov 30, 2010·Modern Rheumatology·Yoshinori TaniguchiYoshio Terada
Oct 24, 2013·Current Rheumatology Reports·Yoshihide Asano, Shinichi Sato
Jul 2, 2009·Nature Reviews. Rheumatology·Francesco Boin, Fredrick Wigley
Dec 2, 2010·Nature Reviews. Rheumatology·Sevdalina Lambova, Ulf Müller-Ladner
Apr 14, 2010·Nature Reviews. Rheumatology·Manuel Ramos-CasalsAntoni Sisó-Almirall
Oct 13, 2011·Nature Reviews. Rheumatology·C Egla Rabinovich
Jul 12, 2012·Nature Reviews. Rheumatology·Ariane L Herrick
Mar 20, 2012·European Heart Journal Cardiovascular Imaging·Sebastian SpethmannFabian Knebel
Dec 15, 2010·Rheumatology·Felice GalluccioMarco Matucci-Cerinic
Aug 12, 2009·Current Opinion in Rheumatology·Stephen C Mathai, Paul M Hassoun
Sep 4, 2009·Current Opinion in Rheumatology·Niamh P Quillinan, Christopher P Denton
Sep 3, 2011·Current Opinion in Rheumatology·Ariane L Herrick
May 11, 2010·Medicine·Marie HudsonUNKNOWN Canadian Scleroderma Research Group (CSRG)
Nov 23, 2013·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Ali AkdoganIhsan Ertenli
Apr 9, 2010·International Journal of Rheumatic Diseases·Geoff Strange, Peter Nash
Jun 20, 2012·International Journal of Rheumatic Diseases·Chingching FoocharoenRatanavadee Nanagara
May 5, 2011·Annals of the Rheumatic Diseases·J BraunD van der Heijde
Sep 24, 2010·International Journal of Rheumatology·Felice Galluccio, Marco Matucci-Cerinic
Dec 22, 2011·International Journal of Rheumatology·Cristina RigamontiAndrew K Burroughs
Feb 9, 2011·Orphanet Journal of Rare Diseases·Rachel RieraVirgínia F M Trevisani
Dec 14, 2011·Immunotherapy·Toshio Tanaka, Tadamitsu Kishimoto
Feb 18, 2014·Journal of Dermatological Science·Masatoshi Jinnin
Oct 15, 2013·Annals of the Rheumatic Diseases·Ulf Müller-LadnerUNKNOWN EUSTAR centres
Sep 28, 2013·Rheumatology International·Shin-ya KawashiriAtsushi Kawakami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.